Dr. Neel Dave Pasricha, MD

Dr. Pasricha practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Pasricha's NPI, 1881056596, was assigned on March 22, 2016. Dr. Pasricha graduated from Duke University School Of Medicine in 2016. Dr. Pasricha holds California license A152628.

Dr. Pasricha's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Pasricha's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Pasricha to 4 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pasricha practices, 5 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Pasricha's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Pasricha is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Pasricha's licenses on file in 2 states: California and Florida.

Dmand AI lists cataract, cataract surgery with lens implant, cold sores or genital herpes, dry eye, eye infection or inflammation, eyelid inflammation, glaucoma and hereditary corneal conditions among the conditions Dr. Pasricha treats.

CMS data shows 489 Medicare services from Dr. Pasricha across 10 procedure codes in 2024, for 129 Medicare patients. Medicare paid $47,680 for them.

CMS counts 129 Medicare patients who saw Dr. Pasricha in 2024. The largest group is 75 to 84, with 51 patients. 67% of them have high cholesterol, and 64% have high blood pressure. 26% are also on Medicaid. Their average risk score is 1.34, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Pasricha's median patient age at 73, with 54% women.

In 2024, Dr. Pasricha wrote 316 Medicare Part D claims for 76 patients. 49% of them were for generic drugs. CMS names the drug for 252 of them, across 9 drugs with 11 or more claims each, at $13,970 in total drug cost. In 2023, CMS named 294 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Pasricha for performance year 2024, reported as part of a group. Dr. Pasricha accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 48 procedures of cataract surgery by Dr. Pasricha, more than 62% of the clinicians it reports for that procedure.

Dmand AI links 34 papers to Dr. Pasricha, published from 2010 to 2025. 2022 was the busiest year, with 5. The most frequent topics are Tomography, Optical Coherence, Cornea and Corneal Diseases. Dr. Pasricha has published most often in Clin Ophthalmol. Dr. Pasricha's most frequent co-authors are Anthony N. Kuo, MD, Gerami Donyel Seitzman, MD and Cynthia A. Toth, MD.

CMS Open Payments shows 89 general payments to Dr. Pasricha from 21 drug and device companies from 2020 to 2025. Grants make up the largest share, 68% of the total. Alcon Research Ltd paid the most, $80,000. It also lists 4 research payments totaling $5,000 from 2023 to 2025.

Dmand AI lists 5 awards for Dr. Pasricha, most recently Excellence and Innovation in Graduate Medical Education Award in 2020.

Dr. Pasricha graduated from Duke University School Of Medicine in 2016. Dr. Pasricha is a member of AAO and ASCRS.

Dr. Pasricha is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.